Back to Search
Start Over
Acute liver failure resulting from discontinuation of nucleoside analogues in chronic hepatitis B patients: A report of two cases.
- Source :
-
Scandinavian Journal of Infectious Diseases . Feb2013, Vol. 45 Issue 2, p158-160. 3p. - Publication Year :
- 2013
-
Abstract
- Lamivudine, adefovir, telbivudine, and entecavir are nucleoside analogues that can inhibit hepatitis B virus replication and are licensed in China by the Food and Drug Administration. This study presents the cases of 2 patients who were chronically infected with HBV and suffered hepatic failure resulting from withdrawal of telbivudine and adefovir, respectively. [ABSTRACT FROM AUTHOR]
- Subjects :
- *CHRONIC hepatitis B
*HEPATITIS B
*VIRAL replication
*NUCLEOSIDES
*PREVENTION
Subjects
Details
- Language :
- English
- ISSN :
- 00365548
- Volume :
- 45
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Scandinavian Journal of Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 85420776
- Full Text :
- https://doi.org/10.3109/00365548.2012.704152